echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The Guangdong Super League is coming!

    The Guangdong Super League is coming!

    • Last Update: 2021-08-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The Guangdong Super League is expected to set off a new round of drug price reduction frenzy



    The purchased varieties involved this time are not unfamiliar to the industry.


    Separately set up two types of procurement product lists, up to 6 shortlisted

    Judging from the specific rules and details, the procurement plan announced by the Guangdong Super League this time is remarkable


    ① If there is only one over-evaluated B purchase order that meets the qualifications for registration, the same product serial number and the same medical insurance dosage form, it will be included in the over-evaluated A purchase order and no over-evaluated B purchase order


    ② If different generic drugs are jointly bid, the generic drugs, original research drugs and reference preparations that have passed the consistency evaluation will be included in the over-rated A purchase order


    ③If the dosage form with the same generic name is exclusive, in principle, the purchase order can be combined according to the same route of administration or the dosage form with a price difference relationship


    Since the list of purchased products distinguishes between over-evaluated and non-over-evaluated types, in the reporting of medical institutions, Guangdong proposes that public medical institutions should fill in the next year’s pre-purchased volume corresponding to the approval number, dosage form, and specifications of the over-evaluated drugs.


    Although the specific proportion of the above groupings has not yet been determined, combined with the selection rules, it will obviously benefit the dominant enterprises in the original market


    The B purchase order is based on whether the product is over-evaluated or not.


    A purchase order product declares the step price and obtains the amount to be allocated

    It is worth mentioning that the procurement plan requires that the declaring company shall reasonably declare the step price of the A purchase order product in accordance with the principle of quantity-price linkage


    The level of the tiered quotation will determine the preferred choice of the selected pharmaceutical companies for the additional amount to be allocated


    In addition, the procurement plan puts forward requirements on the selected enterprises and medical institutions for the increase in use outside the agreement


    Super alliance speeds up the pace of inter-provincial procurement

    Under the requirements of the normalized and institutionalized development of centralized drug procurement, the drug procurement initiated by provincial and local alliances has blossomed across the country, while Guangdong, which is the largest in the domestic pharmaceutical market, is Shanshan.


    In April this year, the Guangdong Provincial Medical Insurance Bureau issued the "Implementation Plan on Promoting the Normalization and Institutionalization of Drug Group Procurement Work (Draft for Comment)", which officially announced the province's drug centralized procurement plan


    From the perspective of the industry, the centralized procurement of the cephalexin alliance led by Guangdong is not just a simple contract renewal.


    However, it is still unknown whether the other 16 provinces in the Guangdong Super League will follow the bids in each batch.
    Judging from the list of reports from Jiangxi, Gansu and other provinces, the number of varieties is not the same.
    Each province follows the bids according to local conditions.
    Or a high probability event
    .
    However, it cannot be denied that the birth of the Guangdong Super League will fully accelerate the pace of inter-provincial volume procurement, and the unification of the national pharmaceutical market's product regulations and prices is expected to be accelerated
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.